Earnings release
Page 1
* eurofins Eurofins reports Core Business organic growth close to 10 % in Q1 2021 and 44.3 % overall 28 April 2021 Q1 2021 revenues increased 41.3 % year - on - year to EUR 1,614m from EUR 1,142m in Q1 2020 , despite a foreign exchange headwind of -3.7 % ( Q1 2021 vs. Q1 2020 average FX rates ) . 。 Very strong organic revenue growth¹ of 44.3 % in Q1 2021 reflecting the significant contribution from COVID - 19 related activities and the rapidly accelerating growth of the Group's Core Business ( excluding COVID - 19 related clinical testing and reagent revenues ) 。 Despite ongoing lockdown restrictions in many key markets , the Group's Core Business delivered close to 10 % organic revenue growth in Q1 2021 ( over 11 % adjusted for public working days ' impact ) against a robust comparable trading period in Q1 2020 ( Q1 2020 organic growth was 4.1 % ) COVID - 19 related clinical testing and reagents activities contributed revenues of close to EUR 400m in Q1 2021 Eurofins remains very active in fighting the pandemic and continued its innovation and product launches throughout Q1 . о Eurofins upgraded its PCR testing kits with enhanced capabilities to detect COVID - 19 Variants of Concern and to help track the spread of these mutations . ○ ○ O In the U.S. , Eurofins launched its direct - to - consumer COVID - 19 Home Collection PCR Kit on Amazon supporting testing at home without a prescription . Eurofins is also partnering with Uber in more than two dozen U.S. cities to deliver its COVID - 19 Home Collection PCR Kits ( click here to see Uber press release ) . Eurofins also launched Home Collection PCR Kits using gargling samples in Germany and Spain . In the UK , the Group is providing low cost at - home PCR testing kits , facilitating greater access to affordable and accurate PCR testing to support a return to travel . Eurofins launched a quantitative antibody ELISA kit to measure immune response to COVID - 19 and vaccines Eurofins set up very high throughput SARS - CoV - 2 Next Generation Sequencing ( NGS ) capacity and won large contracts to support several countries and institutions in their programmes to monitor and identify the emergence and spread of new Variants of Interest or of Concern The Group continues to expand its SAFER @ WORK ™ offering , initiating partnerships with a broad range of companies and organisations including the Radisson Hotel Group , to provide their guests with access to convenient and affordable PCR testing ; Aena , to set up testing facilities at several airports ; Luxaviation to provide COVID - 19 testing to offer an exceptional level of safety to private flights passengers ; and with the International Air Transport Association ( IATA ) to Eurofins Scientific 1/5 April 2021